These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22147800)

  • 1. Clostridium difficile toxins and severe C. difficile infection.
    Johnson S
    J Infect Dis; 2012 Feb; 205(3):353-4. PubMed ID: 22147800
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal models.
    Steele J; Chen K; Sun X; Zhang Y; Wang H; Tzipori S; Feng H
    J Infect Dis; 2012 Feb; 205(3):384-91. PubMed ID: 22147798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TcdB or not TcdB: a tale of two Clostridium difficile toxins.
    Carter GP; Awad MM; Kelly ML; Rood JI; Lyras D
    Future Microbiol; 2011 Feb; 6(2):121-3. PubMed ID: 21366410
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of toxin A and toxin B in the virulence of Clostridium difficile.
    Carter GP; Rood JI; Lyras D
    Trends Microbiol; 2012 Jan; 20(1):21-9. PubMed ID: 22154163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-infection of hamsters with toxin A or toxin B-deficient Clostridium difficile strains.
    Szczesny A; Martirosian G; Cohen S; Silva J
    Pol J Microbiol; 2005; 54(4):301-4. PubMed ID: 16599301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity assessment of Clostridium difficile toxins in rodent models and protection of vaccination.
    Wang S; Rustandi RR; Lancaster C; Hong LG; Thiriot DS; Xie J; Secore S; Kristopeit A; Wang SC; Heinrichs JH
    Vaccine; 2016 Mar; 34(10):1319-23. PubMed ID: 26614590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects.
    Di Bella S; Ascenzi P; Siarakas S; Petrosillo N; di Masi A
    Toxins (Basel); 2016 May; 8(5):. PubMed ID: 27153087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theodore E. Woodward Award. How bacterial enterotoxins work: insights from in vivo studies.
    Lamont JT
    Trans Am Clin Climatol Assoc; 2002; 113():167-80; discussion 180-1. PubMed ID: 12053708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile Toxin Biology.
    Aktories K; Schwan C; Jank T
    Annu Rev Microbiol; 2017 Sep; 71():281-307. PubMed ID: 28657883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol, it's not just for heart disease anymore.
    Kerzmann A; Feig AL
    ACS Chem Biol; 2006 Apr; 1(3):141-4. PubMed ID: 17163660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of toxemia in patients with Clostridium difficile infection.
    Yu H; Chen K; Wu J; Yang Z; Shi L; Barlow LL; Aronoff DM; Garey KW; Savidge TC; von Rosenvinge EC; Kelly CP; Feng H
    PLoS One; 2015; 10(4):e0124235. PubMed ID: 25885671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repetitive domain of Clostridium difficile toxin B exhibits cytotoxic effects on human intestinal epithelial cells and decreases epithelial barrier function.
    Zemljic M; Rupnik M; Scarpa M; Anderluh G; Palù G; Castagliuolo I
    Anaerobe; 2010 Oct; 16(5):527-32. PubMed ID: 20620216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile toxins: mechanism of action and role in disease.
    Voth DE; Ballard JD
    Clin Microbiol Rev; 2005 Apr; 18(2):247-63. PubMed ID: 15831824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile toxins facilitate bacterial colonization by modulating the fence and gate function of colonic epithelium.
    Kasendra M; Barrile R; Leuzzi R; Soriani M
    J Infect Dis; 2014 Apr; 209(7):1095-104. PubMed ID: 24273043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of toxin A negative/B positive Clostridium difficile strains.
    Webb KH
    J Hosp Infect; 2000 Aug; 45(4):331-2. PubMed ID: 10973753
    [No Abstract]   [Full Text] [Related]  

  • 16. Clostridium difficile and Clostridium sordellii toxins, proinflammatory versus anti-inflammatory response.
    Popoff MR
    Toxicon; 2018 Jul; 149():54-64. PubMed ID: 29146177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infection.
    Zhang Z; Chen X; Hernandez LD; Lipari P; Flattery A; Chen SC; Kramer S; Polishook JD; Racine F; Cape H; Kelly CP; Therien AG
    Infect Immun; 2015 Jan; 83(1):405-16. PubMed ID: 25385797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins.
    Chen S; Sun C; Wang H; Wang J
    Toxins (Basel); 2015 Dec; 7(12):5254-67. PubMed ID: 26633511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review: Clostridium difficile-associated disorders/diarrhea and Clostridium difficile colitis: the emergence of a more virulent era.
    Hookman P; Barkin JS
    Dig Dis Sci; 2007 Apr; 52(4):1071-5. PubMed ID: 17380404
    [No Abstract]   [Full Text] [Related]  

  • 20. Morphological changes in adherent cells induced by Clostridium difficile toxins.
    von Eichel-Streiber C; Warfolomeow I; Knautz D; Sauerborn M; Hadding U
    Biochem Soc Trans; 1991 Nov; 19(4):1154-60. PubMed ID: 1794484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.